Bezafibrate increases preβ1-HDL at the expense of HDL(2b) in hypertriglyceridemia

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 11, 2000, Pages 2428-2433

  Miida, Takashi ^a   Sakai, Katsuyuki ^a   Ozaki, Kazuyuki ^a   Nakamura, Yuichi ^a   Yamaguchi, Toshio ^b   Tsuda, Takashi ^b   Kashiwa, Takayuki ^c   Murakami, Toru ^d   Inano, Koichi ^a   Okada, Masahiko ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b Kido Hospital   (Japan)

^c ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d TOKUSHIMA BUNRI UNIVERSITY   (Japan)

Author keywords

Apolipoprotein A I; Cholesteryl ester transfer protein; Hepatic lipase; LpA I; pre HDL

Indexed keywords

APOLIPOPROTEIN A1; BEZAFIBRATE; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; ANTILIPEMIC AGENT; CARRIER PROTEIN; CETP PROTEIN, HUMAN; CHOLESTEROL ESTER TRANSFER PROTEIN; GLYCOPROTEIN; HIGH DENSITY LIPOPROTEIN 2; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PRE BETA HIGH DENSITY LIPOPROTEIN;

ARTICLE; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; MALE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; ADULT; BLOOD; ENZYME ACTIVATION; ENZYMOLOGY; ISOLATION AND PURIFICATION; MIDDLE AGED; MOLECULAR WEIGHT;

ADULT; ANTILIPEMIC AGENTS; BEZAFIBRATE; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; ENZYME ACTIVATION; FEMALE; GLYCOPROTEINS; HIGH-DENSITY LIPOPROTEINS, PRE-BETA; HUMANS; HYPERTRIGLYCERIDEMIA; LIPASE; LIPOPROTEINS, HDL; LIPOPROTEINS, HDL2; MALE; MIDDLE AGED; MOLECULAR WEIGHT; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; TRIGLYCERIDES;

EID: 0033623544     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.11.2428     Document Type: Article

References (33)

1. Early incorporation of cell-derived cholesterol into pre-β-migrating high-density lipoprotein
2. Distribution and functions of lecithin: Cholesterol acyltransferase and cholesteryl ester transfer protein in plasma lipoproteins: Evidence for a functional unit containing these activities together with apolipoproteins A-I and D that catalyzes the esterification and transfer of cell-derived cholesterol
3. Mechanism of transfer of LDL-derived free cholesterol to HDL subfractions in human plasma
4. Cell-derived unesterified cholesterol cycles between different HDLs and LDL for its effective esterification in plasma
5. Pathway of cholesterol efflux from human hepatoma cells
6. High-density lipoprotein subclasses and apolipoprotein A-I
7. 2: A study comparing liver perfusion to in vitro incubation with lipases
8. 1-HDL produced by hepatic lipase
9. Displacement of apoA-I from HDL by apoA-II or its C-terminal helix promotes the formation of preβ1 migrating particles and decreases LCAT activation
10. Serum amyloid A protein generates preβ1 high-density lipoprotein from α-migrating high-density lipoprotein
11. Apolipoprotein-mediated cellular cholesterol efflux
12. Comparison of the effect of bezafibrate on improvement of atherogenic lipoproteins in Japanese familial combined hyperlipidemic patients with or without impaired glucose tolerance
13. Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients
14. Elevated serum triglyceride levels and long-term mortality in patients with coronary heart disease: The Bezafibrate Infarction Prevention (BIP) Registry
15. Interruption of long-term lipid-lowering treatment with bezafibrate in hypertriglyceridaemic patients: Effects on lipoprotein composition, lipase activities and the plasma lipid fatty acid spectrum
16. Effects of slow-release bezafibrate on serum lipids, lipoproteins, apolipoproteins, and postheparin lypolytic activities in patients with type IV and type V hypertriglyceridemia
17. Elevated lipoprotein lipase activity in skeletal muscle tissue during treatment of hypertriglyceridaemic patients with bezafibrate
18. Abnormality of HDL subfractions in cholesteryl ester transfer protein deficiency
19. Preβ1-High-density lipoprotein increases in coronary artery disease
20. LpA-I levels do not reflect preβ1-HDL levels in human plasma
21. High preβ1-HDL levels in hypercholesterolemia are maintained by probucol hut reduced by a low-cholesterol diet
22. Preβ1-high-density lipoprotein (preβ1-HDL) concentration can change with low-density lipoprotein-cholesterol (LDL-C) concentration independent of cholesteryl ester transfer protein (CETP)
23. A new solid-state reagent to iodinate proteins, I: Conditions for the efficient labeling of antiserum
24. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum
25. Plasma lipoprotein lipase, 1: Evaluation of the determination method
26. A new calorimetric method for the determinations of plasma lecithin: Cholesterol acyltransferase activity
27. Effects of bezafibrate therapy on subfractions of plasma low-density lipoprotein and high-density lipoprotein, and on activities of lecithin: Cholesterol acyltransferase and cholesteryl ester transfer protein in patients with hyperlipoproteinemia
28. Presence and formation of 'free apolipoprotein A-I-like' particles in human plasma
29. Regulation of apo A-I gene expression by fibrates
30. Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma
31. Quantitation of preβ-HDL-dependent and nonspecific components of the total efflux of cellular cholesterol and phospholipid
32. Distribution of apolipoprotein E in the plasma of insulin-dependent and noninsulin-dependent diabetics and its relation to cholesterol net transport
33. Abnormal capacity to induce cholesterol efflux and a new LpA-I pre-β particle in type 2 diabetic patients